Actively Recruiting
Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI
Led by University Health Network, Toronto · Updated on 2026-04-16
300
Participants Needed
1
Research Sites
406 weeks
Total Duration
On this page
Sponsors
U
University Health Network, Toronto
Lead Sponsor
V
Vancouver General Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will evaluate whether cardiac MRI T1 and T2 mapping improves our ability to detect early abnormalities in the heart in patients with Fabry disease and identify patients at increase risk of adverse events.
CONDITIONS
Official Title
Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Fabry disease
- Age 18 years or older
You will not qualify if you...
- History of myocardial infarction
- Any condition that prevents having an MRI scan
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Health Network
Toronto, Ontario, Canada, M5G 2C4
Actively Recruiting
Research Team
K
Kate Hanneman
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here